Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: April 2011
-
The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting to be held on June 8, 2011. The proposed agenda is as follows: Morning Session • Greetings, TC Update, and Overview (10:00 – 10:30 am EDT): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600…
-
By James DeGiulio — In March, it appeared that patent reform leading to a unified European Union (EU) patent was on its way to being enacted, after the European Parliament pushed the latest European Commission proposal through despite a dissenting minority of member countries (see "European Parliament Approves Enhanced Cooperation Procedure to Create Unified EP…
-
By Donald Zuhn — USPTO Announces Postponement of Track 1 Examination (Again) On April 21, USPTO Director David Kappos sent a message to Patent Office employees, notifying them that "[t]he Track One expedited patent examination program, scheduled to go into effect on May 4, 2011, is postponed until further notice." Last Friday, the Intellectual Property…
-
By Donald Zuhn — Last week, Dow Jones VentureSource reported that investors put $6.4 billion of venture capital into 661 deals in the first quarter of 2011, which constituted a 35% increase in funding and a 5% increase in deals as compared with the same period last year. VentureSource noted that corporations provided $448 million…
-
By Donald Zuhn — On Friday, USPTO Director David Kappos addressed the impact of budgetary constraints on some of the Patent Office's plans for the coming year. He did so on his Director's Forum blog, where the Director (at right) noted that following enactment of the budget for FY 2011 on April 15, the Office's…
-
The Intellectual Property Law Association of Chicago (IPLAC) Biotech Committee and the John Marshall Law School Center for Intellectual Property Law will offer a panel discussion entitled: "Gene Patents . . . Statutory Subject Matter?" on April 28, 2011 from 1:00 to 2:30 PM (CDT) at the John Marshall Law School in Chicago, IL. The…
-
By James DeGiulio — Pozen Secures Injunction Blocking Par's Generic Treximet Earlier this month, Pozen obtained a preliminary injunction blocking Par Pharmaceutical from marketing a generic version of Pozen's migraine drug Treximet until an infringement suit over the drug is resolved. The dispute between the parties began in November 2008 when Pozen brought suit in…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Genentech, Inc. et al. v. Glaxo Group Ltd. et al.2:11-cv-03065; filed April 12, 2011 in the Central District of California • Plaintiffs: Genentech, Inc.; City of Hope• Defendants: Glaxo Group Ltd.; GlaxoSmithKline LLC; Human Genome…
-
April 27, 2011 – 27th Annual Joint Patent Practice Seminar (Connecticut, New Jersey, New York, and Philadelphia Intellectual Property Law Associations) – New York, NY April 29, 2011 – Ethics in the Practice of Intellectual Property Law (John Marshall Law School Center for Intellectual Property Law) – Chicago, IL April 27-29, 2011 – Patent Strategies…
-
As Nelson Mandela wisely said: "A good head and a good heart are always a formidable combination." IP specialists and creators are among the brightest people in commerce, and we all know innovation is the key to international development. With this spirit, the South African Department of Science and Technology and its co-sponsors encourage you…
Patent Docs 